We systematically examined potential aggression/hostility-related events in a meta-analysis of acute clinical trials of atomoxetine for attention-deficit/hyperactivity disorder (ADHD).
Pediatric patients from 14 trials of atomoxetine were subdivided into a placebo-controlled (atomoxetine n = 1308, placebo n = 806) or active comparator databases (atomoxetine n = 566, methylphenidate n = 472). A third database comprised adult patients from placebo-controlled studies (atomoxetine n = 541, placebo n = 405). A computerized search of adverse events and comments identified patients with potential aggression/hostility events. Mantel–Haenszel incidence differences (MHID) were calculated.
In the placebo-controlled database, we observed 21 atomoxetine and 9 placebo patients with reported aggression/hostility events, MHID of .6% (95% confidence interval [CI]: –.4, 1.7). In the active comparator database, there were seven events in atomoxetine and four in methylphenidate patients, MHID = .2% (95% CI: –1.0,1.3). In the adult database, there were no events in 0 atomoxetine and one placebo patient, MHID = –.3% (95% CI: –.8, .2).
Aggression/hostility-related events occurred in less than 2% of patients and were more frequent in pediatric patients treated with atomoxetine versus placebo (risk ratio of 1.33; not statistically significant). The risk of aggression/hostility events was similar in patients treated with atomoxetine or methylphenidate.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Biological Psychiatry
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Analysis of ordinal categorical data. Wiley, New York1984
- Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive funtioning.J Int Neuropsychol Soc. 2002; 8: 655-672
- Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.Neuropsychopharmacol. 2002; 27: 699-711
- Conners’ Adult ADHD Rating Scales (CAARS). Multi-Health Systems, North Tonawanda, NY1999
- A dose-response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADD children with and without conduct problems.J Child Psychol Psychiatry. 1991; 32: 439-452
- Meta-analysis in clinical trials.Control Clin Trials. 1986; 7: 177-188
- Strattera [package insert]. Author, Indianapolis, IN2005
- Homicide rates among US teenagers and young adults: differences by mechanism, level of urbanization, race, and sex, 1987 through 1995.JAMA. 1998; 280: 423-427
- Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version. Biometrics Research, New York State Psychiatric Institute, New York, NY2000
- Estimation of a common effect parameter from sparse follow-up data.Biometrics. 1985; 41: 55-68
- Alpha-2 adrenoceptor blockade and the response to intruder aggression in Long-Evans rats.Physiol Behav. 1995; 58: 101-106
- Aggression, mania, and hypomania induction associated with atomoxetine.Pediatrics. 2004; 114: 895-896
- Aggressive, prosocial, and nonsocial behavior in hyperactive boys: Dose effects of methylphenidate in naturalistic settings.J Consult Clin Psychol. 1989; 57: 636-643
- Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data.J Am Acad Child Adolesc Psychiatry. 1997; 36: 980-988
- Children’s Hostility Inventory: measurement of aggression and hostility in psychiatric inpatient children.J Clin Child Psychol. 1987; 16: 320-328
- Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial.Pediatrics. 2004; 114: e1-e8
- Age and gender differences in oppositional behavior and conduct problems: a cross-sectional household study of middle childhood and adolescence.J Abnorm Psychol. 2000; 109: 488-503
- The measurement of observer agreement for categorical data.Biometrics. 1977; 33: 159-174
- Aggression and violence: perspectives on integrating animal and human research approaches.Horm Behav. 2003; 44: 156-160
- Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.J Am Acad Child Adolesc Psychiatry. 2005; 44: 530-538
- Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies.Biol Psychiatry. 2003; 53: 112-120
- Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.Am J Psychiatry. 2002; 159: 1896-1901
- Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study.Pediatrics. 2001; 108: e83
- Juvenile delinquency and attention deficit disorder: Boys’ developmental trajectories from age 3 to age 15.Child Dev. 1990; 61: 893-910
- A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder.Arch Gen Psychiatry. 1999; 56: 1073-1086
- Trajectories of boys’ physical aggression, opposition, and hyperactivity on the path to physically violent and nonviolent juvenile delinquency.Child Dev. 1999; 70: 1181-1196
- Bullying behaviors among US youth: Prevalence and association with psychosocial adjustment.JAMA. 2001; 285: 2094-2100
- Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes.J Child Adolesc Psychopharmacol. 1999; 9: 169-184
- Victim as offender in youth violence.Ann Emerg Med. 1995; 26: 609-614
- Precursors of hyperactivity and aggression.J Am Acad Child Adolesc Psychiatry. 1993; 32: 1207-1216
- The Overt Aggression Scale: Overview and guiding principles.J Neuropsychiatry Clin Neurosci. 1991; 3: S22-S29
- Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.J Clin Psychiatry. 2002; 63: 1140-1147
- Assessment of anger: The state-trait anger scale.in: Butcher J.N. Spielberger C.D. Advances in Personality Assessment. Erlbaum, Hillsdale, NJ1983: 161-189
- Churchill Livingstone, London2005 Evidence-based medicine: how to practice and teach EBM. 3rd ed.
- Physical aggression during early childhood: trajectories and predictors.Pediatrics. 2004; 114: e43-e50
- Aggression and disruptive behavior disorders in children and adolescents.Expert Rev Neurother. 2004; 4: 623-632
- Chronic and serious aggressive behavior in children and adolescents are commonly associated with psychiatric disorders.Paediatr Child Health. 2001; 6: 14
- Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats.Horm Behav. 2003; 44: 199-208
- Comparison of specific patterns of antisocial behavior in children with conduct disorder with or without coexisting hyperactivity.J Consult Clin Psychol. 1987; 55: 910-913
- A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.J Am Acad Child Adolesc Psychiatry. 2005; 44: 647-655
- ADHD treatment with once-daily OROS methylphenidate: Final results from a long-term open-label study.J Am Acad Child Adolesc Psychiatry. 2005; 44: 1015-1023
Published online: September 25, 2006
Accepted: May 23, 2006
Received in revised form: May 16, 2006
Received: January 19, 2006
© 2007 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.